The Penrose leadership team is responsible for bringing our mission to life.
Chief Executive Officer
Chief Medical Officer
Dr. Gill is a practicing cardio-oncologist with extensive experience in healthcare management and is a founding member of Penrose TherapeuTx.
Chief Development Officer
Dr. Desai is a trained medical oncologist and hematologist with more than two decades of oncology clinical research expertise across all phases of drug development.
Director of Chemistry, Manufacturing, and Controls
Chief Financial Officer & Chief Operating Officer
Mr. Schutt has over a decade of experience in balance sheet optimization, corporate finance, investment banking, and business development with publicly traded and privately held financial institutions ranging from $250 million to $25 billion in assets. He is also a founding member of Penrose TherapeuTx.